Wordt geladen...
Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
BACKGROUND: Since the precise mechanism for the pathogenesis of systemic lupus erythematosus (SLE) is unknown, no targeted therapies in addition to immunosuppression are available so far. We recently demonstrated that administration of the topoisomerase I (topo I) inhibitor irinotecan at extremely l...
Bewaard in:
| Gepubliceerd in: | Arthritis Res Ther |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5075215/ https://ncbi.nlm.nih.gov/pubmed/27770825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-1144-5 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|